The Call for Innovation in AI and digital medicine in clinical EP is for clinicians, scientists and engineers. The invention or innovation should be on the broad topic of cardiac arrhythmias and tackle a novel approach.
It could be a developed software, a new device, a new use for a drug or other small molecule, or bringing a business approach to an aspect of cardiac rhythm management that can be considered an invention. All pre-commercial revenue stages will be considered, so the idea may be still in basic research, or have progressed all the way to early clinical trials, but it should have moved beyond the idea stage.
Criteria of eligibility:
- Has an innovation with relevance to the first of clinical EP or works in clinical EP
- Has developed an invention